Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Lawsuit Filed to Halt the Takeover by Merck
An investor, who currently holds shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) filed a lawsuit in effort to halt the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per share.
View full press release